Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
Ed Silverman

Ed Silverman

Senior Writer & Pharmalot Columnist at STAT

Contact this person
Email address
e*****@*******.comGet email address
Influence score
71
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

statnews.com

Top contributors to leading psychiatry journals fail to disclose industry payments, analysis finds

A new study found that 14% of $4.5 million paid to authors in two leading psychiatry journals were undisclosed and nearly all of the payments went to researchers conducting drug trials.
18 days ago
statnews.com

South Africa is urged by advocates to issue a compulsory license fo...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention treatment.
29 days ago
statnews.com

Pfizer and Tris agree to $41.5 million settlement with Texas over A...

Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD drug met regulatory hurdles.
about 1 month ago
statnews.com

Trump administration touts moves to provide HIV prevention drug, bu...

The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include South Africa, officials said.
about 1 month ago
statnews.com

Pharmalittle: We're reading about a Merck acquisition, Novo facing ...

Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal
about 1 month ago
statnews.com

Pharmalittle: We're reading about hormone therapy warnings, U.K. an...

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women
about 1 month ago
statnews.com

Pharmalittle: We're reading about a Merck cholesterol pill, the Tru...

Merck pill designed to further lower cholesterol in people on statins but at risk of a serious cardiovascular event cut LDL cholesterol by up to 60%
about 1 month ago
statnews.com

Why one expert thinks Gilead can produce a $25 HIV prevention shot,...

Gilead's new HIV prevention drug Yeztugo costs $28,000 before any rebates or discounts. One expert thinks it can be priced at $25.
about 1 month ago
statnews.com

Pharmalittle: We're reading about a Trump deal with Lilly and Novo,...

The Trump administration is nearing deals with Eli Lilly and Novo Nordisk to lower the prices of their weight loss drugs and expand access to them
about 1 month ago
statnews.com

Pharmalittle: We're reading about a Trump deal with Lilly and Novo,...

The Trump administration is nearing deals with Eli Lilly and Novo Nordisk to lower the prices of their weight loss drugs and expand access to them
about 1 month ago
statnews.com

Novo Nordisk spent millions on weight loss searches that took peopl...

Novo Nordisk spent an estimated $7.5 million on 15,000 paid keywords related to weight loss searches, a new analysis found.
about 2 months ago
statnews.com

Pharmalittle: We're reading about top FDA drug regulator resigning,...

The FDA's top regulator of medicines has resigned after being accused of using his regulatory authority to harm a former business associate
about 2 months ago
statnews.com

Pharmalittle: We're reading about feuds at FDA's CBER, an antibioti...

A feud between the FDA's Vinay Prasad and his staff is threatening the future of the center that regulates vaccines, biological products, and the blood supply
about 2 months ago
statnews.com

Pharmalittle: We're reading about a bidding war for Metsera, HHS pl...

A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to treat obesity
about 2 months ago
statnews.com

Pharmalittle: We're reading about rising GLP-1 use, a psychedelic t...

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey
about 2 months ago
statnews.com

Pharmalittle: We're reading about Organon's CEO resigning, Cigna en...

Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, a practice that has drawn the ire of President Trump
about 2 months ago
statnews.com

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
about 2 months ago
statnews.com

Launch prices for new drugs 'significantly' exceed inflation and of...

New analysis finds the median net price for 154 newly launched drugs, when adjusted for inflation and manufacturer discounts, rose by 51% between 2022 and 2024.
about 2 months ago
statnews.com

CVS Caremark tells AIDS activists Gilead needs to lower the price o...

CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on formularies, according to an email obtained by STAT.
about 2 months ago
statnews.com

Pharmalittle: We're reading about a new Trump drug-pricing probe, N...

The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground for fresh tariffs
about 2 months ago
statnews.com

Gilead agrees not to raise prices on HIV medicines for state AIDS d...

After tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines that are sold to state AIDS Drug Assistance Programs.
about 2 months ago